Two Sigma Securities, LLC Abbott Laboratories Call Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $2.07 Million - $2.45 Million	-20,700 Reduced 34.21%	39,800 $4.54 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $3.05 Million - $3.41 Million	30,300 Added 100.33%	60,500 $6.29 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $7.81 Million - $8.62 Million	-71,300 Reduced 70.25%	30,200 $3.43 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $5.84 Million - $7.14 Million	64,700 Added 175.82%	101,500 $11.2 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $4.15 Million - $4.97 Million	-43,400 Reduced 54.11%	36,800 $3.56 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $7.34 Million - $8.17 Million	72,800 Added 983.78%	80,200 $8.74 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $3.46 Million - $4.07 Million	-35,700 Reduced 82.83%	7,400 $749,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $3.38 Million - $3.97 Million	35,600 Added 474.67%	43,100 $4.73 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $725,700 - $840,225	7,500 New	7,500 $726,000
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $2.23 Million - $2.73 Million	19,600 Added 544.44%	23,200 $2.75 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $2.43 Million - $2.97 Million	-21,000 Reduced 85.37%	3,600 $507,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $2.47 Million - $2.74 Million	21,200 Added 623.53%	24,600 $2.91 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $3.76 Million - $4.42 Million	-35,500 Reduced 91.26%	3,400 $394,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $2.22 Million - $2.41 Million	21,100 Added 118.54%	38,900 $4.26 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $861,416 - $1.05 Million	9,400 Added 111.9%	17,800 $1.94 Million
Q2 2020 Sep 10, 2020	SELL	$76.57 - $98.0 $2.21 Million - $2.82 Million	-28,800 Reduced 77.42%	8,400 $768,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $14.1 Million - $20.7 Million	-225,100 Reduced 85.82%	37,200 $2.94 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $20.6 Million - $22.9 Million	262,300 New	262,300 $22.8 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $17.6 Million - $19.1 Million	-215,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $7.1 Million - $8.28 Million	97,400 Added 82.61%	215,300 $18.1 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $2.33 Million - $2.82 Million	35,200 Added 42.56%	117,900 $9.43 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $13 Million - $14.7 Million	-198,000 Reduced 70.54%	82,700 $5.98 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $2.91 Million - $3.51 Million	47,900 Added 20.58%	280,700 $20.6 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $6.91 Million - $7.63 Million	120,100 Added 106.57%	232,800 $14.2 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $5.53 Million - $6.25 Million	98,200 Added 677.24%	112,700 $6.75 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $778,360 - $833,315	14,500	14,500 $828,000

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.5 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.2 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.89 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.62 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.18 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account